Characterization of inhibitor binding sites of mitochondrial complex I using fluorescent inhibitor (Q44542118)

4 December 2017

Characterization of inhibitor binding sites of mitochondrial complex I using fluorescent inhibitor (English)

1 reference

4 December 2017

Takara Ino

1

1 reference

PubMed ID

12907297

4 December 2017

Takaaki Nishioka

series ordinal

2

1 reference

PubMed ID

12907297

4 December 2017

Hideto Miyoshi

series ordinal

3

1 reference

4 December 2017

1 August 2003

1 reference

Biochimica et Biophysica Acta

4 December 2017

1 reference

4 December 2017

1605

1 reference

4 December 2017

1-3

1 reference

4 December 2017

15-20

1 reference

The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Function of Conserved Acidic Residues in the PSST Homologue of Complex I (NADH:Ubiquinone Oxidoreductase) fromYarrowia lipolytica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

A central functional role for the 49-kDa subunit within the catalytic core of mitochondrial complex I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Evidence for a quinone binding site close to the interface between NUOD and NUOB subunits of Complex I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron-sulfur cluster N2 to quinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

The ND5 subunit was labeled by a photoaffinity analogue of fenpyroximate in bovine mitochondrial complex I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Inhibitors of NADH-ubiquinone reductase: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Structure-activity relationships of some complex I inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Probing the ubiquinone reduction site in bovine mitochondrial complex I using a series of synthetic ubiquinones and inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

The proton-translocating NADH-quinone oxidoreductase in the respiratory chain: the secret unlocked

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Catalytic sector of complex I (NADH:ubiquinone oxidoreductase): subunit stoichiometry and substrate-induced conformation changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Mitochondrial NADH-ubiquinone oxidoreductase (Complex I). Effect of substrates on the fragmentation of subunits by trypsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

The mitochondrial complex I: progress in understanding of catalytic properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

A novel, enzymatically active conformation of the Escherichia coli NADH:ubiquinone oxidoreductase (complex I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal gro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Binding of HQNO to beef-heart sub-mitochondrial particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Triple inhibitor titrations support the functionality of the dimeric character of mitochondrial ubiquinol-cytochrome c oxidoreductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Origin of selective inhibition of mitochondrial complex I by pyridinium-type inhibitor MP-24

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

[3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Probing the ubiquinone reduction site of mitochondrial complex I using novel cationic inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

Specificity of pyridinium inhibitors of the ubiquinone reduction sites in mitochondrial complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2803%2900060-4

10.1016/S0005-2728(03)00060-4

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

12907297